These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1704122

  • 21. [Use of Getah virus for antiviral assay of human interferon].
    Ogiso S, Shirai J, Tuchiya Y, Honda E.
    Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Absence of detectable serum interferon in acute and chronic viral hepatitis.
    Pirovino M, Aguet M, Huber M, Altorfer J, Schmid M.
    Hepatology; 1986 Dec; 6(4):645-7. PubMed ID: 2426168
    [Abstract] [Full Text] [Related]

  • 24. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD, Parfenov VV, Zubanova NA, Pokidysheva LN, Tkach TA.
    Vopr Virusol; 1981 Dec; (6):720-4. PubMed ID: 6175114
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [The effect of the serum inhibitory factor on interferon induction in chronic active hepatitis].
    Tang SB.
    Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):159-61. PubMed ID: 6191928
    [No Abstract] [Full Text] [Related]

  • 27. Purification of human fibroblast interferon prepared in the absence of serum.
    Knight E.
    Methods Enzymol; 1981 Mar; 78(Pt A):417-21. PubMed ID: 6173623
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.
    Gresser I, Brouty-Boyé D, Thomas MT, Macieira-Coelho A.
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1052-8. PubMed ID: 4319881
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Recovery of cell-bound interferon.
    Stewart WE, De Clercq E, De Somer P.
    J Virol; 1972 Oct; 10(4):707-12. PubMed ID: 4343547
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Production, purification, and characterization of rat interferon from transformed rat cells.
    van der Meide PH, Wubben J, Vijverberg K, Schellekens H.
    Methods Enzymol; 1986 Oct; 119():220-30. PubMed ID: 2429144
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.
    Geber WF, Lefkowitz SS, Hung CY.
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):322-7. PubMed ID: 50766
    [Abstract] [Full Text] [Related]

  • 38. Assay of interferon by reduction of viral RNA synthesis: a convenient assay for tracer experiments with monolayer cultures.
    Suzuki J, Iizuka M, Kobayashi S.
    Methods Enzymol; 1981 Apr; 78(Pt A):403-9. PubMed ID: 6173621
    [No Abstract] [Full Text] [Related]

  • 39. [Use of interferon inducers in treating viral diseases].
    Frolov AF, Vovk AD, Diadon ST, Dziublik IV, Trinus EK.
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):58-62. PubMed ID: 6207690
    [Abstract] [Full Text] [Related]

  • 40. [Change in interferon status in patients with acute viral hepatitis during intramuscular and rectal administration of genetically engineered alpha-2-interferon].
    Malinovskaia VV, Neumoina MV, Budanov SV.
    Vopr Virusol; 1994 Aug; 39(6):269-72. PubMed ID: 7536374
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.